Here’s Why Venture Capitalists Like Juno

Aug. 7 (Bloomberg) -- Juno Therapeutics Scientific Co-Founder Michael Jensen and Second Avenue Partners Co-Founder Nick Hanauer discuss the Juno’s favor with venture capitalists. They speak on “Market Makers.” (Source: Bloomberg)
Stock Market May Help Cure China’s Debt Hangover
27:55 - China is turning to its stock market to find a cure for its debt issues. Bloomberg’s Stephen Engle reports on “Trending Business.” (Source: Bloomberg)
  • Drug Smugglers to Face Indonesian Firing Squad
  • People Are in a State of Panic in Nepal: Karki
  • Indian Stocks Have 'Strong Catalysts' for Gains: Rajah